Sexual outcomes in men who have sex with men who underwent radical prostatectomy.
Journal
Prostate cancer and prostatic diseases
ISSN: 1476-5608
Titre abrégé: Prostate Cancer Prostatic Dis
Pays: England
ID NLM: 9815755
Informations de publication
Date de publication:
25 Jun 2024
25 Jun 2024
Historique:
received:
10
03
2024
accepted:
13
06
2024
revised:
31
05
2024
medline:
26
6
2024
pubmed:
26
6
2024
entrez:
25
6
2024
Statut:
aheadofprint
Résumé
Sexual difficulties are a recognized consequence of prostate cancer (PCa) treatments. An estimated one in three men who have sex with men (MSM) receive PCa a diagnosis during their lifetime. MSM may experience all types of sexual dysfunction as reported in men who have sex with women (MSW), along with a number of more specific bothersome problems. This systematic literature review aims to evaluate sexual outcomes in MSM who have undergone radical prostatectomy (RP). A systematic review was carried out following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. The searches were made using relevant keywords in the PubMed, Scopus, and Web of Science databases, thus including the whole literature from January 2000 to November 2023. Studies which did not allow to retrieve data on sexual outcomes on MSM treated with RP for PCa were excluded. Data on sexual outcomes and health-related quality of life (HRQoL) were retrieved, mostly including changes in libido, erectile function, ejaculatory disorders, orgasm, climacturia, changes in role-in-sex identity, changes in sexual partnerships, and the presence of painful receptive anal intercourses (AI). CRD42024502592. Six articles met the inclusion criteria. In total, data of 260 patients were analyzed. Three main themes emerged: (a) MSM may experience specific sexual dysfunctions due to the different dynamics of their intimacy; (b) the lack of tool validated on gay and bisexual population to assess sexual outcomes (c) the need for a tailored approach that also takes into account sexual orientation throughout the oncological journey. MSM undergoing RP may experience similar sexual problems as MSW. Painful AI should be considered a potential post-operative adverse outcome in MSM. Future studies should prioritize validating a questionnaire that explores AI. Healthcare providers should adopt a tailored approach that takes into account sexual orientation throughout the cancer journey.
Sections du résumé
BACKGROUND
BACKGROUND
Sexual difficulties are a recognized consequence of prostate cancer (PCa) treatments. An estimated one in three men who have sex with men (MSM) receive PCa a diagnosis during their lifetime. MSM may experience all types of sexual dysfunction as reported in men who have sex with women (MSW), along with a number of more specific bothersome problems. This systematic literature review aims to evaluate sexual outcomes in MSM who have undergone radical prostatectomy (RP).
METHODS
METHODS
A systematic review was carried out following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. The searches were made using relevant keywords in the PubMed, Scopus, and Web of Science databases, thus including the whole literature from January 2000 to November 2023. Studies which did not allow to retrieve data on sexual outcomes on MSM treated with RP for PCa were excluded. Data on sexual outcomes and health-related quality of life (HRQoL) were retrieved, mostly including changes in libido, erectile function, ejaculatory disorders, orgasm, climacturia, changes in role-in-sex identity, changes in sexual partnerships, and the presence of painful receptive anal intercourses (AI).
PROSPERO ID
UNASSIGNED
CRD42024502592.
RESULTS
RESULTS
Six articles met the inclusion criteria. In total, data of 260 patients were analyzed. Three main themes emerged: (a) MSM may experience specific sexual dysfunctions due to the different dynamics of their intimacy; (b) the lack of tool validated on gay and bisexual population to assess sexual outcomes (c) the need for a tailored approach that also takes into account sexual orientation throughout the oncological journey.
CONCLUSIONS
CONCLUSIONS
MSM undergoing RP may experience similar sexual problems as MSW. Painful AI should be considered a potential post-operative adverse outcome in MSM. Future studies should prioritize validating a questionnaire that explores AI. Healthcare providers should adopt a tailored approach that takes into account sexual orientation throughout the cancer journey.
Identifiants
pubmed: 38918583
doi: 10.1038/s41391-024-00861-9
pii: 10.1038/s41391-024-00861-9
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Nature Limited.
Références
Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17–48. https://doi.org/10.3322/caac.21763
doi: 10.3322/caac.21763
pubmed: 36633525
Yazdanpanah O, Benjamin DJ, Rezazadeh Kalebasty A. Prostate cancer in sexual minorities: epidemiology, screening and diagnosis, treatment, and quality of life. Cancers. 2023;15:2654 https://doi.org/10.3390/cancers15092654
doi: 10.3390/cancers15092654
pubmed: 37174119
pmcid: 10177609
Rosser BRS, Hunt SL, Capistrant BD, Kohli N, Konety BR, Mitteldorf D, et al. Understanding prostate cancer in gay, bisexual, and other men who have sex with men and transgender women: a review of the literature. Curr Sex Health Rep. 2019;11:430–41. https://doi.org/10.1007/s11930-019-00234-7
doi: 10.1007/s11930-019-00234-7
pubmed: 31929765
pmcid: 6953377
Mitchell E, Ziegler E. Sexual dysfunction in gay and bisexual prostate cancer survivors: a concept analysis. J Homosex. 2022;69:1119–39. https://doi.org/10.1080/00918369.2021.1905384
doi: 10.1080/00918369.2021.1905384
pubmed: 33818298
Wheldon CW, Bates AJ, Polter EJ, Rosser BRS, Kapoor A, Talley KMC, et al. Unrecognized sexual dysfunction in gay and bisexual men after prostate cancer treatment: the antecedents and impact of anodyspareunia. J Sex Med. 2023;20:515–24. https://doi.org/10.1093/jsxmed/qdad009
doi: 10.1093/jsxmed/qdad009
pubmed: 36796863
pmcid: 10078940
Levin RJ. Prostate-induced orgasms: a concise review illustrated with a highly relevant case study. Clin Anat. 2018;31:81–5. https://doi.org/10.1002/ca.23006
doi: 10.1002/ca.23006
pubmed: 29265651
Hartman M-E, Irvine J, Currie KL, Ritvo P, Trachtenberg L, Louis A, et al. Exploring gay couples’ experience with sexual dysfunction after radical prostatectomy: a qualitative study. J Sex Marital Ther. 2014;40:233–53. https://doi.org/10.1080/0092623X.2012.726697
doi: 10.1080/0092623X.2012.726697
pubmed: 23899045
Rosser BRS, Capistrant B, Torres MB, Konety B, Merengwa E, Mitteldorf D, et al. The effects of radical prostatectomy on gay and bisexual men’s sexual functioning and behavior: qualitative results from the restore study. Sex Relat Ther. 2016;31:432–45. https://doi.org/10.1080/14681994.2016.1217985
doi: 10.1080/14681994.2016.1217985
McConkey RW, Holborn C. Exploring the lived experience of gay men with prostate cancer: A phenomenological study. Eur J Oncol Nurs. 2018;33:62–69. https://doi.org/10.1016/j.ejon.2018.01.013
doi: 10.1016/j.ejon.2018.01.013
pubmed: 29551179
Moore MA, Batten J, Lazenby M. Sexual minority men and the experience of undergoing treatment for prostate cancer: An integrative review. Eur J Cancer Care. 2019;28:e13031 https://doi.org/10.1111/ecc.13031
doi: 10.1111/ecc.13031
Parums DV. Editorial: review articles, systematic reviews, meta-analysis, and the updated preferred reporting items for systematic reviews and meta-analyses (PRISMA) 2020 guidelines. Med Sci Monit. 2021;27:e934475 https://doi.org/10.12659/MSM.934475
doi: 10.12659/MSM.934475
pubmed: 34421116
pmcid: 8394590
Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane handbook for systematic reviews of interventions. Cochrane Database Syst Rev. 2019;10:ED000142.
pubmed: 31643080
Knoll T, Omar MI, Maclennan S, Hernández V, Canfield S, Yuan Y, et al. Key steps in conducting systematic reviews for underpinning clinical practice guidelines: methodology of the European Association of Urology. Eur Urol. 2018;73:290–300.
doi: 10.1016/j.eururo.2017.08.016
pubmed: 28917594
Howick J, Chalmers I, Glasziou P, Greenhalgh T, Heneghan C, Liberati A, et al. The Oxford 2011 levels of evidence. 2011. http://www.cebm.net/index.aspx?o=5653
Lee TK, Handy AB, Kwan W, Oliffe JL, Brotto LA, Wassersug RJ, et al. Impact of prostate cancer treatment on the sexual quality of life for men-who-have-sex-with-men. J Sex Med. 2015;12:2378–86. https://doi.org/10.1111/jsm.13030
doi: 10.1111/jsm.13030
pubmed: 26537853
Rosser BRS, Kohli N, Polter EJ, Lesher L, Capistrant BD, Konety BR, et al. The sexual functioning of gay and bisexual men following prostate cancer treatment: results from the restore study. Arch Sex Behav. 2020;49:1589–600. https://doi.org/10.1007/s10508-018-1360-y
doi: 10.1007/s10508-018-1360-y
pubmed: 31016492
Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000;56:899–905. https://doi.org/10.1016/s0090-4295(00)00858-x
doi: 10.1016/s0090-4295(00)00858-x
pubmed: 11113727
Rosen RC, Catania J, Pollack L, Althof S, O’Leary M, Seftel AD. Male Sexual Health Questionnaire (MSHQ): scale development and psychometric validation. Urology. 2004;64:777–82. https://doi.org/10.1016/j.urology.2004.04.056
doi: 10.1016/j.urology.2004.04.056
pubmed: 15491719
Rosen RC, Catania JA, Althof SE, Pollack LM, O’Leary M, Seftel AD, et al. Development and validation of four-item version of Male Sexual Health Questionnaire to assess ejaculatory dysfunction. Urology. 2007;69:805–9. https://doi.org/10.1016/j.urology.2007.02.036
doi: 10.1016/j.urology.2007.02.036
pubmed: 17482908
Wheldon CW, Polter EJ, Rosser BRS, Kapoor A, Talley KMC, Haggart R, et al. Pain and loss of pleasure in receptive anal sex for gay and bisexual men following prostate cancer treatment: results from the restore-1 study. J Sex Res. 2022;59:826–33. https://doi.org/10.1080/00224499.2021.1939846
doi: 10.1080/00224499.2021.1939846
pubmed: 34219559
McInnis MK, Pukall CF. Sex after prostate cancer in gay and bisexual men: a review of the literature. Sex Med Rev. 2020;8:466–72. https://doi.org/10.1016/j.sxmr.2020.01.004
doi: 10.1016/j.sxmr.2020.01.004
pubmed: 32169431
Gaither TW, Vincent NW, Piqueiras E, Barzallo D, Siapno A, Williams KC, et al. Atlas of the receptive anal sex experience among people with prostates. J Sex Med. 2023;20:126–38. https://doi.org/10.1093/jsxmed/qdac024
doi: 10.1093/jsxmed/qdac024
pubmed: 36763914
Amarasekera C, Wong V, Jackson K, Yura E, Patel M, Manjunath A, et al. A pilot study assessing aspects of sexual function predicted to be important after treatment for prostate cancer in gay men: an underserved domain highlighted. LGBT Health. 2020;7:271–6. https://doi.org/10.1089/lgbt.2018.0245
doi: 10.1089/lgbt.2018.0245
pubmed: 32584648
Salonia A, Adaikan G, Buvat J, Carrier S, El-Meliegy A, Hatzimouratidis K, et al. Sexual rehabilitation after treatment for prostate cancer-part 1: Recommendations from the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2017;14:285–96.
doi: 10.1016/j.jsxm.2016.11.325
pubmed: 28262099
Salonia A, Adaikan G, Buvat J, Carrier S, El-Meliegy A, Hatzimouratidis K, et al. sexual rehabilitation after treatment for prostate cancer-part 2: Recommendations from the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2017;14:297–315.
doi: 10.1016/j.jsxm.2016.11.324
pubmed: 28262100
Cheng PJ. Sexual dysfunction in men who have sex with men. Sex Med Rev. 2022;10:130–41. https://doi.org/10.1016/j.sxmr.2021.01.002
doi: 10.1016/j.sxmr.2021.01.002
pubmed: 33931381
Ussher JM, Perz J, Rose D, Kellett A, Dowsett G. Sexual rehabilitation after prostate cancer through assistive aids: a comparison of gay/bisexual and heterosexual men. J Sex Res. 2019;56:854–69. https://doi.org/10.1080/00224499.2018.1476444
doi: 10.1080/00224499.2018.1476444
pubmed: 29913078
Hart TL, Coon DW, Kowalkowski MA, Zhang K, Hersom JI, Goltz HH, et al. Changes in sexual roles and quality of life for gay men after prostate cancer: challenges for sexual health providers. J Sex Med. 2014;11:2308–17. https://doi.org/10.1111/jsm.12598
doi: 10.1111/jsm.12598
pubmed: 24888965
pmcid: 4415517
Asencio M, Blank T, Descartes L, Crawford A. The prospect of prostate cancer: A challenge for gay men’s sexualities as they age. Sex Res Social Policy. 2009;6:38–51.
Polter EJ, Kohli N, Rosser BRS, Talley KMC, Wheldon CW, Hoefer CJ, et al. Creation and psychometric validation of the Sexual Minorities and Prostate Cancer Scale (SMACS) in sexual minority patients- the restore-2 study. J Sex Med. 2022;19:529–40.
doi: 10.1016/j.jsxm.2021.12.012
pubmed: 35131199
pmcid: 8893317
Alexis O, Worsley AJ. The experiences of gay and bisexual men post-prostate cancer treatment: a meta-synthesis of qualitative studies. Am J Mens Health. 2018;12:2076–88. https://doi.org/10.1177/1557988318793785
doi: 10.1177/1557988318793785
pubmed: 30112965
pmcid: 6199434
Berner AM, Hughes DJ, Tharmalingam H, Baker T, Heyworth B, Banerjee S, et al. An evaluation of self-perceived knowledge, attitudes and behaviours of UK oncologists about LGBTQ+ patients with cancer. ESMO Open. 2020;5:e000906.
doi: 10.1136/esmoopen-2020-000906
pubmed: 33208489
pmcid: 7677327
Rose D, Ussher JM, Perz J. Let’s talk about gay sex: gay and bisexual men’s sexual communication with healthcare professionals after prostate cancer. Eur J Cancer Care. 2017;26. https://doi.org/10.1111/ecc.12469
Anderson EM, Gu L, Oyekunle T, De Hoedt AM, Wiggins E, Gay CJ, et al. Lifestyle and sociodemographic factors associated with treatment choice of clinically localized prostate cancer in an equal access healthcare system. Prostate Cancer Prostatic Dis. 2022;25:593–5.
doi: 10.1038/s41391-022-00551-4
pubmed: 35618798
Rosser BRS, Rider GN, Kapoor A, Talley KMC, Haggart R, Kohli N, et al. Every urologist and oncologist should know about treating sexual and gender minority prostate cancer patients: translating research findings into clinical practice. Transl Androl Urol. 2021;10:3208–25. https://doi.org/10.21037/tau-20-1052
doi: 10.21037/tau-20-1052
pubmed: 34430423
pmcid: 8350223